Dr Murat Ayhan
- Especialidad: Oncólogo clínico
- 36 años de experiencia
- Idiomas:Inglés
- Consultorio: Turquía, Estambul, Liv Hospital Vadistanbul
El profesor asociado Murat Ayhan se especializa en el tratamiento del cáncer de mama en el Liv Hospital Vadistanbul, con una participación activa en ensayos clínicos internacionales.
- Participar en ensayos de fase II y III para el cáncer de mama con receptores hormonales positivos
- Publicar investigaciones sobre los resultados de supervivencia en el cáncer de mama triple negativo
- Ser experto en enfoques de oncología molecular
- Tener experiencia en el manejo de casos localmente avanzados y metastásicos
Reseñas de paciente
Servicios médicos
- TEP/TC
- Resonancia magnética de un área
- Colonoscopia
- Angiografía
- TC (tomografía computarizada)
- RM de cuerpo entero
- Fibroscan
- Biopsia de mama
- Biopsia de pulmón
- PET-RM
¿Qué tal su experiencia?
Formación académica
Specialization & Oncology Approach
Dr. Ayhan treats advanced treatment protocols for a wide range of solid tumors. His primary areas of interest include breast and lung cancer, and colorectal and gastrointestinal cancers. He also treats gynecological and urogenital cancers and provides molecular oncology through targeted therapies.
He uses molecular diagnostics to identify specific gene aberrations, such as Pik3ca mutations. This data helps him select targeted agents like tyrosine kinase inhibitors. He also treats bone cancer and liver malignancies because these conditions often require specialized oncological management.
Clinical Research & Trial Experience
Dr. Ayhan is a researcher for several multicenter international studies. He evaluates the efficacy of new endocrine therapies and subcutaneous immunotherapies. His research work includes evaluating GDC-9545 and GDC-0077 for hormone receptor-positive breast cancer.
Furthermore, he compares subcutaneous versus intravenous atezolizumab for lung cancer. He also investigates apalutamide for high-risk hormone-sensitive prostate cancer. Additionally, he studies biomarker identification for patients with advanced stage urothelial cancer and fibroblast growth factor receptor gene aberrations.
Academic & Professional Experience
Dr. Ayhan has practiced at several major Turkish medical institutions. He achieved the rank of Associate Professor in 2023. His previous roles include:
- Liv Hospital Ulus
- Adıyaman University Training and Research Hospital
- Istanbul Umraniye Training and Research Hospital
Education & Training
- 2001 – Kızıltepe Anatolian High School
- 2007 – Dicle University Faculty of Medicine – Medical Degree
- 2014 – Istanbul Medeniyet University Göztepe Training and Research Hospital – Residency
- 2021 – Kartal City Hospital – Specialist Training
- 2023 – Associate Professorship in Medical Oncology
Scientific Publications & Books
Dr. Ayhan has authored over 30 peer-reviewed articles in journals such as Future Oncology and Journal of Chemotherapy. He has written chapters for the Physicians' Chemotherapy Cancer Drug Manual. Additionally, he contributed to books on internal medicine emergencies and gastrointestinal stromal tumors.
His notable publications include:
- "Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy"
- "Real-world data on efficacy and safety of first-line alectinib treatment"
- "Drug interactions and side effects of targeted agents" (Book Chapter)
- "Survival analysis of patients with triple-negative breast cancer"
- "Prognostic significance of mucinous histology in left sided metastatic colorectal cancers"
- "Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19"
También le puede interesar
Pagos y Beneficios
Nuestros servicios no tienen costo
El pago se realiza directamente en la clínica o mediante transferencia a su cuenta bancaria oficial.
Algunas clínicas pueden requerir un depósito como parte de su política.
Pague cómodamente en cuotas flexibles.
Reciba recompensas por recomendar Bookimed a sus amigos.